1、 WITKOWSKI B, Lelièvre J, Barragán M J L, et al.Increased tolerance to artemisinin in plasmodium falciparum is mediated by a quiescence mechanism[J]. Antimicrob Agents Chemother, 2010, 54(5):1872-1877. WITKOWSKI B, Lelièvre J, Barragán M J L, et al.Increased tolerance to artemisinin in plasmodium falciparum is mediated by a quiescence mechanism[J]. Antimicrob Agents Chemother, 2010, 54(5):1872-1877.
2、 JUNG M, KIM H, NAM K Y, et al. Three-dimensional structure of Plasmodium falciparum Ca2+-ATPase (Pf ATP6) and docking of artemisinin derivatives to Pf ATP6[J].Bioorg Med Chem Lett, 2005, 15(12): 2994-2997. JUNG M, KIM H, NAM K Y, et al. Three-dimensional structure of Plasmodium falciparum Ca2+-ATPase (Pf ATP6) and docking of artemisinin derivatives to Pf ATP6[J].Bioorg Med Chem Lett, 2005, 15(12): 2994-2997.
3、 KRISHNA S, WOODROW C J, STAINES H M, et al. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance[J]. Trends Mol Med, 2006, 12(5): 200-205. KRISHNA S, WOODROW C J, STAINES H M, et al. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance[J]. Trends Mol Med, 2006, 12(5): 200-205.
4、 WALKER D J, PITSCH J L, PENG M M, et al. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii[J]. Antimicrob Agents Chemother,2000, 44(2): 344-347. WALKER D J, PITSCH J L, PENG M M, et al. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii[J]. Antimicrob Agents Chemother,2000, 44(2): 344-347.
5、 杨亚明,李雪平,张苍林.云南省抗氯喹恶性疟原虫双氢青蒿素抗性株体外培育与单克隆品系的建立[J]. 中国病原生物学杂志,2013,8(8):714-717. 杨亚明,李雪平,张苍林.云南省抗氯喹恶性疟原虫双氢青蒿素抗性株体外培育与单克隆品系的建立[J]. 中国病原生物学杂志,2013,8(8):714-717.
6、 LI W, MO W, SHEN D, et al. Yeast model uncovers dual roles of mitochondria in the action of artemisinin[J]. Plos Genet, 2005, 1(3): 36. LI W, MO W, SHEN D, et al. Yeast model uncovers dual roles of mitochondria in the action of artemisinin[J]. Plos Genet, 2005, 1(3): 36.
7、 ECKSTEIN-LUDWIG U, WEBB R J, van GOETHEM I D A, et al. Artemisinins target the SERCA of plasmodium falciparum[J]. Nature, 2003, 424(6951): 957-961. ECKSTEIN-LUDWIG U, WEBB R J, van GOETHEM I D A, et al. Artemisinins target the SERCA of plasmodium falciparum[J]. Nature, 2003, 424(6951): 957-961.
8、 徐进,郑莹. 青蒿素类药物作用机制的探讨[J]. 药学进展,2002,26(5):274-278. 徐进,郑莹. 青蒿素类药物作用机制的探讨[J]. 药学进展,2002,26(5):274-278.
9、 孙辰,李坚,周兵. 青蒿素类药物的作用机制:一个长久未决的基础研究挑战[J]. 中国科学:生命科学,2012,42(5):345-354. 孙辰,李坚,周兵. 青蒿素类药物的作用机制:一个长久未决的基础研究挑战[J]. 中国科学:生命科学,2012,42(5):345-354.
10、 TANABE K, ZAKERI S, PALACPAC N M Q, et al. Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (Pf ATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies[J]. Antimicrob Agents Chemother, 2011,55(1): 94-100. TANABE K, ZAKERI S, PALACPAC N M Q, et al. Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (Pf ATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies[J]. Antimicrob Agents Chemother, 2011,55(1): 94-100.
11、 郑全芳,杨志刚,孙红祥,等. 青蒿素及其衍生物药理作用研究进展[J]. 中国兽药杂志,2006,40(1):40-44. 郑全芳,杨志刚,孙红祥,等. 青蒿素及其衍生物药理作用研究进展[J]. 中国兽药杂志,2006,40(1):40-44.
12、 PANDEY A V, TEKWANI B L, SINGH R L, et al. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite[J]. J Biol Chem, 1999, 274(27): 19383-19388. PANDEY A V, TEKWANI B L, SINGH R L, et al. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite[J]. J Biol Chem, 1999, 274(27): 19383-19388.
13、 祝叶华. 青蒿素研究进展[J]. 科技导报,2015, 33(20): 36-41. 祝叶华. 青蒿素研究进展[J]. 科技导报,2015, 33(20): 36-41.
14、 TARANTO A G, CARNEIRO J W,OLIVEIRA F G,et al.The role of C-centered radicals on the mechanism of action of artemisinin[J]. J Mol Struct Theochem, 2002,580(1): 207-215. TARANTO A G, CARNEIRO J W,OLIVEIRA F G,et al.The role of C-centered radicals on the mechanism of action of artemisinin[J]. J Mol Struct Theochem, 2002,580(1): 207-215.
15、 SELMECZI K, ROBERT A, CLAPAROLS C, et al. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin[J]. FEBS let, 2004, 556(1): 245-248. SELMECZI K, ROBERT A, CLAPAROLS C, et al. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin[J]. FEBS let, 2004, 556(1): 245-248.
16、 OLLIARO P L, HAYNES R K, MEUNIER B, et al. Possible modes of action of the artemisinin-type compounds[J]. Trends Parasitol, 2001, 17(3): 122-126. OLLIARO P L, HAYNES R K, MEUNIER B, et al. Possible modes of action of the artemisinin-type compounds[J]. Trends Parasitol, 2001, 17(3): 122-126.
17、 MESHNICK S R. Artemisinin:mechanisms of action,resistance and toxicity[J]. Int J Parasitol, 2002, 32(13): 1655-1660. MESHNICK S R. Artemisinin:mechanisms of action,resistance and toxicity[J]. Int J Parasitol, 2002, 32(13): 1655-1660.
18、 王安平,高琪,顾亚萍. 用pfcrt点突变基因检测技术检测恶性疟原虫氯喹抗药性的初步研究[J]. 中国血吸虫病防治杂志,2005,17(2):120-123. 王安平,高琪,顾亚萍. 用pfcrt点突变基因检测技术检测恶性疟原虫氯喹抗药性的初步研究[J]. 中国血吸虫病防治杂志,2005,17(2):120-123.
19、 KRISHNA S, BUSTAMANTE L, HAYNES R K, et al. Artemisinins:their growing importance in medicine[J]. Trends Pharmacol Sci, 2008, 29(10): 520-527. KRISHNA S, BUSTAMANTE L, HAYNES R K, et al. Artemisinins:their growing importance in medicine[J]. Trends Pharmacol Sci, 2008, 29(10): 520-527.
20、 张逸龙,潘卫庆. 恶性疟原虫对青蒿素产生抗性的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 418-424. 张逸龙,潘卫庆. 恶性疟原虫对青蒿素产生抗性的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 418-424.
